211 related articles for article (PubMed ID: 34975523)
1. Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure.
Brown AK; Nichols A; Coley CA; Ekperikpe US; McPherson KC; Shields CA; Poudel B; Cornelius DC; Williams JM
Front Physiol; 2021; 12():765305. PubMed ID: 34975523
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing MIP3
Ekperikpe US; Poudel B; Shields CA; Mandal S; Cornelius DC; Williams JM
J Pharmacol Exp Ther; 2023 Mar; 384(3):445-454. PubMed ID: 36507846
[TBL] [Abstract][Full Text] [Related]
3. Depletion of macrophages slows the early progression of renal injury in obese Dahl salt-sensitive leptin receptor mutant rats.
Poudel B; Shields CA; Brown AK; Ekperikpe U; Johnson T; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1489-F1499. PubMed ID: 32390513
[TBL] [Abstract][Full Text] [Related]
4. Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats.
Shields CA; Poudel B; McPherson KC; Brown AK; Ekperikpe US; Browning E; Sutton L; Cornelius DC; Williams JM
Front Physiol; 2020; 11():566403. PubMed ID: 33071820
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with IL-25 increases renal M2 macrophages and reduces renal injury in obese Dahl salt-sensitive rats during the prepubescent stage.
Poudel B; Ekperikpe US; Mandal S; Wilson GE; Shields CA; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F87-F98. PubMed ID: 37167270
[TBL] [Abstract][Full Text] [Related]
6. Metformin reduces insulin resistance and attenuates progressive renal injury in prepubertal obese Dahl salt-sensitive rats.
Ekperikpe US; Mandal S; Holt SJ; Daniels JK; Johnson TD; Cooper JS; Safir SM; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2023 Sep; 325(3):F363-F376. PubMed ID: 37498548
[TBL] [Abstract][Full Text] [Related]
7. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.
McPherson KC; Shields CA; Poudel B; Johnson AC; Taylor L; Stubbs C; Nichols A; Cornelius DC; Garrett MR; Williams JM
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F911-F921. PubMed ID: 32068459
[TBL] [Abstract][Full Text] [Related]
8. Abatacept Decreases Renal T-cell Infiltration and Renal Inflammation and Ameliorates Progressive Renal Injury in Obese Dahl Salt-sensitive Rats Before Puberty.
Ekperikpe US; Mandal S; Bhopatkar AA; Shields CA; Coley CA; Chambers CL; Johnson TD; Cornelius DC; Williams JM
J Cardiovasc Pharmacol; 2024 Jun; 83(6):635-645. PubMed ID: 38547515
[TBL] [Abstract][Full Text] [Related]
9. Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.
McPherson KC; Taylor L; Johnson AC; Didion SP; Geurts AM; Garrett MR; Williams JM
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F793-F804. PubMed ID: 27465994
[TBL] [Abstract][Full Text] [Related]
10. The SS
Poudel B; Shields CA; Ekperikpe US; Brown AK; Travis OK; Maury JC; Fitzgerald S; Smith SV; Cornelius DC; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2022 Apr; 322(4):R299-R308. PubMed ID: 35107024
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats.
Kojima N; Williams JM; Slaughter TN; Kato S; Takahashi T; Miyata N; Roman RJ
Physiol Rep; 2015 Jul; 3(7):. PubMed ID: 26169541
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effects of empagliflozin in type 1 and type 2 models of diabetic nephropathy superimposed with hypertension.
Williams JM; Murphy SR; Wu W; Border JJ; Fan F; Roman RJ
Geroscience; 2022 Dec; 44(6):2845-2861. PubMed ID: 35767209
[TBL] [Abstract][Full Text] [Related]
14. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade.
Spires D; Poudel B; Shields CA; Pennington A; Fizer B; Taylor L; McPherson KC; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F977-F985. PubMed ID: 29846112
[TBL] [Abstract][Full Text] [Related]
15. Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in Dahl salt-sensitive rats.
Ray SC; Patel B; Irsik DL; Sun J; Ocasio H; Crislip GR; Jin CH; Chen J; Baban B; Polichnowski AJ; O'Connor PM
Clin Sci (Lond); 2018 Jun; 132(11):1179-1197. PubMed ID: 29650676
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats.
Kojima N; Williams JM; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):464-72. PubMed ID: 23492941
[TBL] [Abstract][Full Text] [Related]
17. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil prevents high-fat diet-induced hypertension and renal glomerular injury in Dahl SS rats.
Spradley FT; De Miguel C; Hobbs J; Pollock DM; Pollock JS
Physiol Rep; 2013 Nov; 1(6):e00137. PubMed ID: 24400139
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
Tian N; Thrasher KD; Gundy PD; Hughson MD; Manning RD
Hypertension; 2005 May; 45(5):934-9. PubMed ID: 15837840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
